Beximco Pharmaceuticals【BXP】銘柄情報

Beximco Pharmaceuticals Plc (BXP) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

45.00

( - )

買値

40.00

売値

50.00

出来高

113,395

45.00 日の範囲 48.30

0.00 52 週間の範囲 0.00

時価総額

200.75M

前日終値

45.00

始値

45.00

時刻

25000

48.5

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

1,154,554p

発行済株式数

446,112,089

配当利回り

4.75 (3.38%)

PER

7.25

1 株当たり利益 (EPS)

19.39

歳入

53.93B

純利益

8.65B

Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, co... Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals PLC. was incorporated in 1976 and is headquartered in Dhaka, Bangladesh. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

beximcopharma.com

本社

Dhaka, Bangladesh

設立

1976

Beximco Pharmaceuticals Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker BXP. The last closing price for Beximco Pharmaceuticals was 45p. Over the last year, Beximco Pharmaceuticals shares have traded in a share price range of 0.00p to 0.00p.

Beximco Pharmaceuticals currently has 446,112,089 shares in issue. The market capitalisation of Beximco Pharmaceuticals is £200.75 million. Beximco Pharmaceuticals has a price to earnings ratio (PE ratio) of 7.25.